BioArctic Says Early Alzheimer's Drug Treats First Patient in Sweden

MT Newswires · 1d ago
11:27 AM EDT, 09/22/2026 (MT Newswires) -- BioArctic (BIOA-B.ST) said the first patient was treated with Leqembi on Tuesday after launching the treatment for early Alzheimer's disease at a private clinic in Sweden. Leqembi received European Union approval in April 2025, according to a Tuesday release. The Swedish biopharmaceutical company has the right to commercialize the drug in the Nordic region together with its partner, Eisai.